@article{4a8c5db13a9046af92214cd27b7542af,
title = "Omicron: A SARS-CoV-2 variant of real concern",
keywords = "COVID-19, Humans, Mutation, SARS-CoV-2, Spike Glycoprotein, Coronavirus",
author = "Pia Gattinger and Inna Tulaeva and Kristina Borochova and Bernhard Kratzer and Doris Trapin and Anna Kropfm{\"u}ller and Pickl, \{Winfried F\} and Rudolf Valenta",
note = "Funding Information: This study was supported by grants from {\"O}sterreichische Forschungsf{\"o}rderungsgesellschaft, Grant number: 35721032; Austrian Science Fund, Grant number: DK-W1248; Viravaxx AG; Medizinisch-Wissenschaftlichen Fonds des B{\"u}rgermeisters der Bundeshauptstadt Wien, Grant numbers: COVID001 and COVID006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We wish to acknowledge the help of Doris Werjant-Locmele and Anna Guentcheva regarding the recruitment and administration of study subjects. We are grateful to all individuals who participated in our study. Funding Information: This study was supported by grants from {\"O}sterreichische Forschungsf{\"o}rderungsgesellschaft, Grant number: 35721032; Austrian Science Fund, Grant number: DK‐W1248; Viravaxx AG; Medizinisch‐Wissenschaftlichen Fonds des B{\"u}rgermeisters der Bundeshauptstadt Wien, Grant numbers: COVID001 and COVID006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding Information: Rudolf Valenta has received research grants from HVD Life‐Sciences, Vienna, Austria, WORG Pharmaceuticals, Hangzhou, China and from Viravaxx AG, Vienna, Austria. He serves as consultant for Viravaxx AG and WORG Pharmaceuticals. The other authors have no conflict of interest to declare. ",
year = "2022",
month = may,
doi = "10.1111/all.15264",
language = "English",
volume = "77",
pages = "1616--1620",
journal = "Allergy: European Journal of Allergy and Clinical Immunology",
issn = "0105-4538",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "5",
}
SDG 3 – Gute Gesundheit und Wohlergehen